- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Rubicon Organics announced the preparation for the approval of a EU-GMP certification started at its facility in Delta, BC.
Rubicon Organics (CSE:ROMJ,OTCQX:ROMJF) announced the preparation for the approval of a European Union Good Manufacturing Practices (EU-GMP) certification started at its facility in Delta, BC.
As quoted in the press release:
The EU-GMP certification is given to companies who demonstrate a high degree of precision and consistency in their manufacturing procedures, and is a requirement for the import of medical cannabis products into the European market.
Working with Q&C, GMP consultants who have extensive experience across cannabis and international pharmaceutical industries, the BC Facility recently completed a trial audit as the first step in ensuring the correct controls and compliance are in place for European sales.
“We expect access to EU-GMP certified organic cannabis will be a game changer for medical markets both locally and internationally,” said Jesse McConnell, Co-Founder and CEO of Rubicon Organics. “With Q&C supporting our process, we look forward to providing access to our extensive genetics and top-tier terpene profiles around the world.”
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.